Literature DB >> 25260340

Polymorphism in the corticotropin-releasing factor receptor 1 (CRF1-R) gene plays a role in shaping the high anxious phenotype of Marchigian Sardinian alcohol-preferring (msP) rats.

Andrea Cippitelli1, Lydia O Ayanwuyi, Estelle Barbier, Esi Domi, Jose M Lerma-Cabrera, Francisca Carvajal, Giulia Scuppa, Hongwu Li, Massimo Ubaldi, Markus Heilig, Marisa Roberto, Roberto Ciccocioppo.   

Abstract

INTRODUCTION: Marchigian Sardinian alcohol-preferring (msP) rats exhibit innate preference for alcohol along with anxious phenotype. In these animals, two single-nucleotide polymorphisms in position -1,836 and -2,097 from the first start codon of the CRF1-R transcript have been found.
MATERIALS AND METHODS: Here, we examined whether these point mutations account for the heightened anxiety-like behavior and stress responsiveness of msP rats. We rederived the msP rats to obtain two distinct lines carrying the wild-type (GG) and point mutations (AA), respectively.
RESULTS: CRF1-R gene expression analysis revealed significant dysregulation of the system in the extended amygdala of AA rats. At the behavioral level, using the elevated plus maze, we found that both AA and GG lines had higher basal anxiety compared to Wistar rats. In the defensive burying test, AA rats showed decreased burying behavior compared to the GG and the unselected Wistar lines. Freezing/immobility did not differ among AA and GG but was higher than that of Wistars. The selective CRF1-R antagonist antalarmin (0, 10, and 20 mg/kg) reduced burying behavior in Wistar animals. However, antalarmin (10 mg/kg) tended to increase rather than reducing this behavior when tested in the msP lines, an effect that appeared more marked in the GG as compared to the AA line.
CONCLUSION: The present data suggest that rats with msP genetic background are more anxious and show different sensitivity to stress and CRF1-R blockade than Wistars. The point mutations occurring in the CRF1-R gene do not seem to influence basal anxiety while they appear to affect active responses to stress.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25260340      PMCID: PMC4339612          DOI: 10.1007/s00213-014-3743-7

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  66 in total

1.  Local repeated corticotropin-releasing factor infusion exacerbates anxiety- and fear-related behavior: differential involvement of the basolateral amygdala and medial prefrontal cortex.

Authors:  E Y Bijlsma; M L F van Leeuwen; K G C Westphal; B Olivier; L Groenink
Journal:  Neuroscience       Date:  2010-11-18       Impact factor: 3.590

2.  Pharmacological blockade of corticotropin-releasing hormone receptor 1 (CRH1R) reduces voluntary consumption of high alcohol concentrations in non-dependent Wistar rats.

Authors:  Andrea Cippitelli; Ruslan Damadzic; Erick Singley; Annika Thorsell; Roberto Ciccocioppo; Robert L Eskay; Markus Heilig
Journal:  Pharmacol Biochem Behav       Date:  2011-10-20       Impact factor: 3.533

3.  In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.

Authors:  E L Webster; D B Lewis; D J Torpy; E K Zachman; K C Rice; G P Chrousos
Journal:  Endocrinology       Date:  1996-12       Impact factor: 4.736

Review 4.  Defensive burying in rodents: ethology, neurobiology and psychopharmacology.

Authors:  Sietse F De Boer; Jaap M Koolhaas
Journal:  Eur J Pharmacol       Date:  2003-02-28       Impact factor: 4.432

5.  A role for the bed nucleus of the stria terminalis, but not the amygdala, in the effects of corticotropin-releasing factor on stress-induced reinstatement of cocaine seeking.

Authors:  S Erb; J Stewart
Journal:  J Neurosci       Date:  1999-10-15       Impact factor: 6.167

6.  Corticotropin releasing factor-induced amygdala gamma-aminobutyric Acid release plays a key role in alcohol dependence.

Authors:  Marisa Roberto; Maureen T Cruz; Nicholas W Gilpin; Valentina Sabino; Paul Schweitzer; Michal Bajo; Pietro Cottone; Samuel G Madamba; David G Stouffer; Eric P Zorrilla; George F Koob; George R Siggins; Loren H Parsons
Journal:  Biol Psychiatry       Date:  2010-01-08       Impact factor: 13.382

7.  Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development.

Authors:  G W Smith; J M Aubry; F Dellu; A Contarino; L M Bilezikjian; L H Gold; R Chen; Y Marchuk; C Hauser; C A Bentley; P E Sawchenko; G F Koob; W Vale; K F Lee
Journal:  Neuron       Date:  1998-06       Impact factor: 17.173

Review 8.  Stress-related neuropeptides and alcoholism: CRH, NPY, and beyond.

Authors:  Roberto Ciccocioppo; Donald R Gehlert; Andrey Ryabinin; Simranjit Kaur; Andrea Cippitelli; Annika Thorsell; Anh D Lê; Philip A Hipskind; Chafiq Hamdouchi; Jianliang Lu; Erik J Hembre; Jeffrey Cramer; Min Song; David McKinzie; Michelle Morin; Daina Economidou; Serena Stopponi; Nazzareno Cannella; Simone Braconi; Marsida Kallupi; Giordano de Guglielmo; Maurizio Massi; David T George; Jody Gilman; Jacqueline Hersh; Johannes T Tauscher; Stephen P Hunt; Daniel Hommer; Markus Heilig
Journal:  Alcohol       Date:  2009-11       Impact factor: 2.405

9.  Corticotropin-releasing hormone receptor (type I) antisense targeting reduces anxiety.

Authors:  T Skutella; J C Probst; U Renner; F Holsboer; C Behl
Journal:  Neuroscience       Date:  1998-08       Impact factor: 3.590

10.  Activation of central CRF receptor 1 by cortagine results in enhanced passive coping with a naturalistic threat in mice.

Authors:  Philip Tovote; Catherine Borna Farrokhi; Rachael M K Gonzales; Udo Schnitzbauer; D Caroline Blanchard; Robert J Blanchard; Joachim Spiess
Journal:  Psychoneuroendocrinology       Date:  2009-12-24       Impact factor: 4.905

View more
  18 in total

Review 1.  Preclinical evidence implicating corticotropin-releasing factor signaling in ethanol consumption and neuroadaptation.

Authors:  T J Phillips; C Reed; R Pastor
Journal:  Genes Brain Behav       Date:  2015-01       Impact factor: 3.449

2.  Glutamatergic transmission in the central nucleus of the amygdala is selectively altered in Marchigian Sardinian alcohol-preferring rats: Alcohol and CRF effects.

Authors:  Melissa A Herman; Florence P Varodayan; Christopher S Oleata; George Luu; Dean Kirson; Markus Heilig; Roberto Ciccocioppo; Marisa Roberto
Journal:  Neuropharmacology       Date:  2015-10-28       Impact factor: 5.250

Review 3.  Building better strategies to develop new medications in Alcohol Use Disorder: Learning from past success and failure to shape a brighter future.

Authors:  Nazzareno Cannella; Massimo Ubaldi; Alessio Masi; Massimo Bramucci; Marisa Roberto; Angelo Bifone; Roberto Ciccocioppo
Journal:  Neurosci Biobehav Rev       Date:  2019-05-18       Impact factor: 8.989

4.  Pharmacological stress is required for the anti-alcohol effect of the α3β4* nAChR partial agonist AT-1001.

Authors:  Andrea Cippitelli; Gloria Brunori; Kelly A Gaiolini; Nurulain T Zaveri; Lawrence Toll
Journal:  Neuropharmacology       Date:  2015-02-14       Impact factor: 5.250

5.  Neuropeptide S differently modulates alcohol-related behaviors in alcohol-preferring and non-preferring rats.

Authors:  Nazzareno Cannella; Marsida Kallupi; Hong Wu Li; Serena Stopponi; Carlo Cifani; Roberto Ciccocioppo; Massimo Ubaldi
Journal:  Psychopharmacology (Berl)       Date:  2016-05-28       Impact factor: 4.530

6.  CB1 and ethanol effects on glutamatergic transmission in the central amygdala of male and female msP and Wistar rats.

Authors:  Dean Kirson; Christopher Shaun Oleata; Loren Howell Parsons; Roberto Ciccocioppo; Marisa Roberto
Journal:  Addict Biol       Date:  2017-06-28       Impact factor: 4.280

7.  phMRI, neurochemical and behavioral responses to psychostimulants distinguishing genetically selected alcohol-preferring from genetically heterogenous rats.

Authors:  A Bifone; A Gozzi; A Cippitelli; A Matzeu; E Domi; H Li; G Scuppa; N Cannella; M Ubaldi; F Weiss; R Ciccocioppo
Journal:  Addict Biol       Date:  2018-10-17       Impact factor: 4.280

8.  Constitutive Increases in Amygdalar Corticotropin-Releasing Factor and Fatty Acid Amide Hydrolase Drive an Anxious Phenotype.

Authors:  Luis A Natividad; Matthew W Buczynski; Melissa A Herman; Dean Kirson; Christopher S Oleata; Cristina Irimia; Ilham Polis; Roberto Ciccocioppo; Marisa Roberto; Loren H Parsons
Journal:  Biol Psychiatry       Date:  2017-01-13       Impact factor: 13.382

9.  Varenicline decreases nicotine but not alcohol self-administration in genetically selected Marchigian Sardinian alcohol-preferring (msP) rats.

Authors:  Giulia Scuppa; Andrea Cippitelli; Lawrence Toll; Roberto Ciccocioppo; Massimo Ubaldi
Journal:  Drug Alcohol Depend       Date:  2015-09-08       Impact factor: 4.492

Review 10.  Shaping vulnerability to addiction - the contribution of behavior, neural circuits and molecular mechanisms.

Authors:  Gabor Egervari; Roberto Ciccocioppo; J David Jentsch; Yasmin L Hurd
Journal:  Neurosci Biobehav Rev       Date:  2017-05-29       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.